Litigation - STAT

Pharmalot By Ed Silverman

Pharmalittle: Trump grows frustrated over drug pricing; FDA enforcement declines under Trump

Pharmalot By Ed Silverman

Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue

Pharmalot By Ed Silverman

Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug

Pharmalot By Ed Silverman

Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says

Pharmalot By Ed Silverman

A federal appeals court just slammed the door on Allergan’s deal with the Mohawk tribe

Pharmalot By Ed Silverman

Pharmalittle: Amgen migraine drug costs less than expected; J&J halts development on Alzheimer’s drug

Pharmalot By Ed Silverman

Pharmalittle: Sanofi to refund Philippines for dengue vaccine; Google backs universal flu vaccine

Pharmalot By Ed Silverman

Allergan may face a setback to its Mohawk deal thanks to a new ruling

Pharmalot By Ed Silverman

Three more drug makers allegedly used nurses to promote medicines

Pharmalot By Ed Silverman

Pharmalittle: Anthem to start its own PBM; J&J wins a big court reversal

Pharmalot By Ed Silverman

Allergan to pay $4 million to settle sex discrimination charges by former sales reps

Pharmalot By Ed Silverman

Pharmalittle: Shire CFO will be leaving; J&J hit with $417 million talc verdict

Pharmalot By Ed Silverman

Pfizer must face NYU in a lawsuit over royalties on a cancer drug, again

Pharmalot By Ed Silverman

Winners and losers: Who had a good week – and who didn’t

Pharmalot By Ed Silverman

Glaxo fights a lawsuit that has all sorts of interesting twists

Pharmalot By Ed Silverman

Drug makers continue to face more securities fraud lawsuits

Pharmalot By Ed Silverman

Pfizer slammed for banning employee class action complaints

Pharmalot By Ed Silverman

Most Read

Amgen and Novartis file dueling lawsuits over their deal to market a migraine drug

Minnesota becomes first state to sue major insulin makers over price-gouging

A reversal of fortunes: Judge voids order Gilead must pay $2.5B to Merck over a patent dispute

Boehringer Ingelheim abandons biosimilar sales outside the U.S.

Pharmalittle: Supermarkets sue over generic price fixing; Daiichi can collect that $550 million award

Drug makers are sued for scheming to illegally fix insulin prices

Aetna pressures whistleblower who alleged CVS Caremark ripped off Medicare

Pharmalittle: Generic chief at Novartis unit leaves; how Ned Sharpless got to the top of the FDA

All Coverage

Pharmalittle: Trump grows frustrated over drug pricing; FDA enforcement declines under Trump

Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue

Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug

Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says

A federal appeals court just slammed the door on Allergan’s deal with the Mohawk tribe

Pharmalittle: Amgen migraine drug costs less than expected; J&J halts development on Alzheimer’s drug

Pharmalittle: Sanofi to refund Philippines for dengue vaccine; Google backs universal flu vaccine

Allergan may face a setback to its Mohawk deal thanks to a new ruling

Three more drug makers allegedly used nurses to promote medicines

Pharmalittle: Anthem to start its own PBM; J&J wins a big court reversal

Allergan to pay $4 million to settle sex discrimination charges by former sales reps

Pharmalittle: Shire CFO will be leaving; J&J hit with $417 million talc verdict

Pfizer must face NYU in a lawsuit over royalties on a cancer drug, again

Winners and losers: Who had a good week – and who didn’t

Glaxo fights a lawsuit that has all sorts of interesting twists

Drug makers continue to face more securities fraud lawsuits

Pfizer slammed for banning employee class action complaints

Gilead ordered to pay $2.54 billion to Merck over hepatitis C patents